SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-14-000408
Filing Date
2014-02-11
Accepted
2014-02-11 08:01:18
Documents
4
Period of Report
2014-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8k.htm 8-K 36773
2 EXHIBIT 2.1 ex2-1.htm EX-2.1 438099
3 EXHIBIT 99.1 ex99-1.htm EX-99.1 17832
4 GRAPHIC logo.jpg GRAPHIC 26996
  Complete submission text file 0001493152-14-000408.txt   531375
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 14591336
SIC: 2834 Pharmaceutical Preparations